# Effect of BMS-986165 on the Blood Levels of Metformin

> **NCT04671953** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 36 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** BMS-986165
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT04671953
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-18
- **Primary completion:** 2021-03-03
- **Final completion:** 2021-03-30
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2021-11-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04671953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04671953, "Effect of BMS-986165 on the Blood Levels of Metformin". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04671953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*